First author | Case nationality | Region | Age, years | Included number | Malignant disease | Detected sample | Analysis method | Survival analysis |
---|---|---|---|---|---|---|---|---|
Hsu, 2015 | Chinese Taiwan | Asia | 53.80mean | 140 | EOC | Tissue | IHC | PFS |
Tu, 2015 | USA | North America | NA | 595 | CRC | Tissue | IHC | OS |
Faria, 2015 | Germany/Brazil | Europe | <Â 45.80 | 124 (DFS)/188 (OS) | ACC | Tissue | IHC | OS/DFS |
Qin, 2014 | China | Asia | 50.00median | 90 | Glioma | Tissue | IHC | OS/PFS |
Wang, 2014 | China | Asia | 59.60mean | 298 | GC | Tissue | IHC | OS/DFS |
Liu, 2013 | China | Asia | 46.00median | 86 | Breast cancer | Tissue | IHC | OS |
Xu, 2013 | China | Asia | 56.00median | 229 | GC | Tissue | IHC | OS |
Yin, 2013 | China | Asia | 49.00median | 57 | HCC | Tissue | qRT-PCR | OS/RFS |
Ma, 2013 | USA | North America | 60.78mean | 343 | EOC | Tissue | AQUA | OS/PFS |
Wu, 2013 | China | Asia | 60.00mean | 72 | OSCC | Tissue | IHC | OS/DFS |
Feng, 2012 | USA | North America | 50.00median | 569 | Breast cancer | Tissue | AQUA | OS |
Hamano, 2012 | Japan | Asia | 65.00mean | 161 | OC | Tissue | IHC | OS/DFS |
Qiu, 2012 | China | Asia | 50.00median | 53 | HCC | Tissue | PCR | OS/RFS |
Rodini, 2012 | Brazil | South America | NA | 37 | Medulloblastoma | Tissue | qRT-PCR | OS |
Korshunov, 2012 | Germany | Europe | <Â 18.00 | 816 | ETMR | Tissue | IHC | OS |
Kim, 2011 | South Korea | Asia | 48.00median | 38 | NPC | Tissue | IHC | OS/PFS |